Skip NavigationSkip to Content
Return Return to Search Results

Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs

  1. Author:
    Sabourin, Katherine R.
    Ogolla, Sidney
    Daud, Ibrahim I.
    Jackson, Conner L.
    Miley,Wendell
    Labo,Nazzarena
    Whitby,Denise
    Rochford, Rosemary

  2. Author Address

    Univ Colorado, Dept Epidemiol, Anschutz Med Campus, Aurora, CO 80045 USA.Univ Colorado, CU Sch Med, Dept Immunol & Microbiol, Anschutz Med Campus,12800 E 19th Ave, Aurora, CO 80045 USA.Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.US Army, Med Res Labs, Kericho, Kenya.Univ Colorado, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA.Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA.
    1. Year: 2020
    2. Date: DEC 26
    3. Epub Date: 2020 11 26
  2. Journal: INFECTIOUS AGENTS AND CANCER
  3. BMC,
    1. 15
    2. 1
  5. Type of Article: Article
  6. Article Number: 71
  7. ISSN: 1750-9378
  1. Abstract:

    Background: Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in sub-Saharan African children can range up to 50% by age 2 years but factors affecting early age of KSHV infection are not well understood. Malaria during pregnancy has been associated with hindered transplacental transfer of antibodies to several pathogens but whether it affects transplacental transfer of KSHV antibodies is unknown. We aimed to determine if in utero malaria exposure reduced the transfer of KSHV antibodies across the placenta. Methods: A cohort study in Kisumu, Kenya enrolled pregnant women at their first antenatal clinic (ANC) visit and followed them through delivery. We included 70 KSHV-positive, HIV-negative mothers and their children. KSHV antibody levels were measured by ELISA (K8.1, ORF73) and multiplex assay (K8.1, ORF73, K10.5, ORF38, ORF50). Transplacental transfer of antibodies was measured by the cord to maternal blood ratio (CMR) of KSHV antibodies. Malaria during pregnancy was defined as detection of Plasmodium falciparum (Pf) DNA at any ANC visit or delivery. Among women with malaria during pregnancy, we examined time of last malaria infection prior to delivery (< 27 vs. 27+ weeks gestation) and malaria incidence rate (MIR) (episodes/100 person-weeks). Results: KSHV seroprevalence (positive for K8.1 or ORF73 by ELISA) among pregnant women was 88%. Neither malaria during pregnancy, malaria infection timing, nor MIR were associated with maternal delivery KSHV antibody blood levels. Maternal delivery and cord blood KSHV antibody levels were highly correlated but these correlations did not differ by malaria during pregnancy. KSHV transplacental antibody transfer was not associated with malaria during pregnancy, malaria infection timing, nor MIR. Conclusions: Malaria during pregnancy does not appear to affect transfer of KSHV antibodies across the placenta.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1186/s13027-020-00336-1
  3. PMID: 33292357
  4. PMCID: PMC7690029
  5. View record in Web of Science®
  6. WOS: 000593064900001

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel